Cancer Research Cell Death Mechanisms and Cancer Therapy  Telomeres
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Navarro-Perán, E.
Right arrow Articles by Rodríguez-López, J. N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Navarro-Perán, E.
Right arrow Articles by Rodríguez-López, J. N.
[Cancer Research 65, 2059-2064, March 15, 2005]
© 2005 American Association for Cancer Research


Priority Reports

The Antifolate Activity of Tea Catechins

Enma Navarro-Perán1, Juan Cabezas-Herrera2, Francisco García-Cánovas1, Marcus C. Durrant3, Roger N.F. Thorneley4 and José Neptuno Rodríguez-López1

1 Grupo de Investigación de Enzimología, Departamento de Bioquímica y Biología Molecular A, Facultad de Biología, Universidad de Murcia; 2 Servicio de Análisis Clínicos, Hospital Universitario Virgen de la Arrixaca, Murcia, Spain; and 3 Computational Biology Group and 4 Department of Biological Chemistry, John Innes Centre, Norwich, United Kingdom

Requests for reprints: José Neptuno Rodríguez-López, Grupo de Investigación de Enzimología, Departamento de Bioquímica y Biología Molecular A, Facultad de Biología, Universidad de Murcia, E-30100 Espinardo, Murcia, Spain. Phone: 34-968398284; Fax: 34-968364147; E-mail: neptuno{at}um.es.

A naturally occurring gallated polyphenol isolated from green tea leaves, (–)-epigallocatechin gallate (EGCG), has been shown to be an inhibitor of dihydrofolate reductase (DHFR) activity in vitro at concentrations found in the serum and tissues of green tea drinkers (0.1-1.0 µmol/L). These data provide the first evidence that the prophylactic effect of green tea drinking on certain forms of cancer, suggested by epidemiologic studies, is due to the inhibition of DHFR by EGCG and could also explain why tea extracts have been traditionally used in "alternative medicine" as anticarcinogenic/antibiotic agents or in the treatment of conditions such as psoriasis. EGCG exhibited kinetics characteristic of a slow, tight-binding inhibitor of 7,8-dihydrofolate reduction with bovine liver DHFR (KI = 0.109 µmol/L), but of a classic, reversible, competitive inhibitor with chicken liver DHFR (KI = 10.3 µmol/L). Structural modeling showed that EGCG can bind to human DHFR at the same site and in a similar orientation to that observed for some structurally characterized DHFR inhibitor complexes. The responses of lymphoma cells to EGCG and known antifolates were similar, that is, a dose-dependent inhibition of cell growth (IC50 = 20 µmol/L for EGCG), G0-G1 phase arrest of the cell cycle, and induction of apoptosis. Folate depletion increased the sensitivity of these cell lines to antifolates and EGCG. These effects were attenuated by growing the cells in a medium containing hypoxanthine-thymidine, consistent with DHFR being the site of action for EGCG.

Key Words: green tea • catechins • dihydrofolate reductase • EGCG • antifolates




This article has been cited by other articles:


Home page
Am J EpidemiolHome page
T. Naganuma, S. Kuriyama, M. Kakizaki, T. Sone, N. Nakaya, K. Ohmori-Matsuda, A. Hozawa, Y. Nishino, and I. Tsuji
Green Tea Consumption and Hematologic Malignancies in Japan: The Ohsaki Study
Am. J. Epidemiol., September 15, 2009; 170(6): 730 - 738.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
T. D. Shanafelt, T. G. Call, C. S. Zent, B. LaPlant, D. A. Bowen, M. Roos, C. R. Secreto, A. K. Ghosh, B. F. Kabat, M.-J. Lee, et al.
Phase I Trial of Daily Oral Polyphenon E in Patients With Asymptomatic Rai Stage 0 to II Chronic Lymphocytic Leukemia
J. Clin. Oncol., August 10, 2009; 27(23): 3808 - 3814.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
M. Inoue, K. Robien, R. Wang, D. J. Van Den Berg, W.-P. Koh, and M. C. Yu
Green tea intake, MTHFR/TYMS genotype and breast cancer risk: the Singapore Chinese Health Study
Carcinogenesis, October 1, 2008; 29(10): 1967 - 1972.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
B. D. Zeitlin, I. J. Zeitlin, and J. E. Nor
Expanding Circle of Inhibition: Small-Molecule Inhibitors of Bcl-2 as Anticancer Cell and Antiangiogenic Agents
J. Clin. Oncol., September 1, 2008; 26(25): 4180 - 4188.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
D. J. Castro, Z. Yu, C. V. Lohr, C. B. Pereira, J. N. Giovanini, K. A. Fischer, G. A. Orner, R. H. Dashwood, and D. E. Williams
Chemoprevention of dibenzo[a,l]pyrene transplacental carcinogenesis in mice born to mothers administered green tea: primary role of caffeine
Carcinogenesis, August 1, 2008; 29(8): 1581 - 1586.
[Abstract] [Full Text] [PDF]


Home page
Drug Metab. Dispos.Home page
T.-T. Kao, K.-C. Wang, W.-N. Chang, C.-Y. Lin, B.-H. Chen, H.-L. Wu, G.-Y. Shi, J.-N. Tsai, and T.-F. Fu
Characterization and Comparative Studies of Zebrafish and Human Recombinant Dihydrofolate Reductases--Inhibition by Folic Acid and Polyphenols
Drug Metab. Dispos., March 1, 2008; 36(3): 508 - 516.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
S. B. van Waalwijk van Doorn-Khosrovani, J. Janssen, L. M. Maas, R. W.L. Godschalk, J. G. Nijhuis, and F. J. van Schooten
Dietary flavonoids induce MLL translocations in primary human CD34+ cells
Carcinogenesis, August 1, 2007; 28(8): 1703 - 1709.
[Abstract] [Full Text] [PDF]


Home page
J Antimicrob ChemotherHome page
M. D. Navarro-Martinez, F. Garcia-Canovas, and J. N. Rodriguez-Lopez
Tea polyphenol epigallocatechin-3-gallate inhibits ergosterol synthesis by disturbing folic acid metabolism in Candida albicans
J. Antimicrob. Chemother., June 1, 2006; 57(6): 1083 - 1092.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
M. D. Lucock and P. D. Roach
The Antifolate Activity of Tea Catechins
Cancer Res., September 15, 2005; 65(18): 8573 - 8573.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2005 by the American Association for Cancer Research.